MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E. Yohe, Javed Khan, Young Song et al.|Science Translational Medicine|2018Cited by 155
Protection against human papillomavirus type 16‐E7 oncogene‐induced tumorigenesis by in vivo expression of dominant‐negative c‐<i>jun</i>†Matthew R. Young, Nancy H. Colburn, Linda Farrell et al.|Molecular Carcinogenesis|2002Cited by 41
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E. Hebron, Marielle E. Yohe, Xiaolin Wan et al.|Clinical Cancer Research|2022Cited by 21